Drreddys Laboratories | RDY - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Canopy Growth CAD 758.17M 22.16M 2025-12
Cipla INR 329.19B 16.3B 2025-09
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Drreddys Laboratories INR 4.14B 107.72M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Pacira USD 693.11M 34.1M 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Richter Gedeon HUF 1.4T 65.96B 2025-12
Sun Pharmaceuticals INR 778.2B 56.02B 2025-09
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12